Australian Doctor recently reported on an expert-written guideline urging Australian GPs to inform patients with mild dementia that a multivitamin supplement had been shown to help.

In the guideline, the product is twice referred to by its generic name Fortasyn Connect, but is sold as Souvenaid.

The wording of the guideline refers to the findings of an RTC involving the supplement and specifically says patients “should be informed of these results and the availability of Fortasyn Connect in Australia”.

You can read the full wording yourself at the end of this article.